Search

everythinglearnresearchcommunity

for

Search:↓

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

Caffeine can protect scalp hair follicles from damage caused by UV radiation.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Collagen and TGF-β2 help maintain hair cell shape and youthfulness.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.